Physician profile
Julia Lange
NPI 1508024795
$1,034.76
in general payments reported to CMS, 2019-2025
20 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $39.66 · 2022: $141 · 2023: $162 · 2024: $314 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $151.25 | 2019-2025 | Myosure Tissue Removal Device, Fetal Fibronectin Enzyme Immunoassay, Fluent Fluid Management System |
| Astellas Pharma US INC | $119.43 | 2023-2025 | Veozah |
| Biogen, INC. | $106.18 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $95.87 | 2019-2025 | |
| Exeltis, USA INC. | $68.55 | 2022-2024 | Slynd |
| Organon LLC | $59.06 | 2022-2024 | |
| Coopersurgical, INC. | $55.99 | 2020-2025 | Paragard T 380a, Endosee |
| Daiichi Sankyo INC. | $47.00 | 2020-2023 | Injectafer |
| Pfizer INC. | $46.63 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $38.30 | 2019-2023 | Gardasil 9 |
| Becton, Dickinson and Company | $35.62 | 2024 | Bd Max System, Bd Max Instrument |
| Abbvie INC. | $32.93 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $30.31 | 2023-2025 | |
| Axonics, INC. | $29.22 | 2023 | Axonics, Bulkamid |
| Therapeuticsmd, INC. | $29.03 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $28.46 | 2025 | 1788 |
| Sumitomo Pharma America, INC. | $23.95 | 2025 | Myfembree |
| Alexion Pharmaceuticals, INC. | $13.80 | 2019 | |
| Boston Scientific Corporation | $12.08 | 2022 | |
| Channel Medsystems, INC. | $11.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Lange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.